Common Stock, Shares, Issued of AVENUE THERAPEUTICS, INC. from Q4 2016 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Avenue Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q4 2016 to Q3 2025.
  • Avenue Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2025 was 3.18M shares, a 98.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

AVENUE THERAPEUTICS, INC. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 3.18M +1.58M +98.5% Sep 30, 2025 10-Q 2025-11-13
Q2 2025 3.18M +1.99M +168% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 3.18M +2.59M +439% Mar 31, 2025 10-Q 2025-05-15
Q4 2024 2.11M +1.77M +518% Dec 31, 2024 10-Q 2025-11-13
Q3 2024 1.6M -7.36M -82.1% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 1.19M -6.73M -85% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 590K -6.24M -91.4% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 341K -4.43M -92.9% Dec 31, 2023 10-K 2025-03-31
Q3 2023 8.96M +7.48M +505% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 7.92M -14.2M -64.2% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 6.83M -15.3M -69.2% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 4.77M 0 0% Dec 31, 2022 10-K 2024-03-18
Q3 2022 1.48M -15.3M -91.2% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 22.1M +5.39M +32.2% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 22.1M +5.39M +32.2% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 4.77M -12M -71.5% Dec 31, 2021 10-K 2023-03-31
Q3 2021 16.8M +45.9K +0.27% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 16.7M +45.3K +0.27% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 16.7M +65.3K +0.39% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 16.7M +65.6K +0.39% Dec 31, 2020 10-K 2022-03-25
Q3 2020 16.7M +86.4K +0.52% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 16.7M +143K +0.86% Jun 30, 2020 10-Q 2020-08-14
Q1 2020 16.7M +126K +0.76% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 16.7M +6.01M +56.4% Dec 31, 2019 10-K 2021-03-31
Q3 2019 16.7M +6M +56.3% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 16.6M +6.01M +56.9% Jun 30, 2019 10-Q 2019-08-14
Q1 2019 16.6M +6.01M +56.9% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 10.7M +403K +3.92% Dec 31, 2018 10-K 2020-03-30
Q3 2018 10.7M +397K +3.87% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 10.6M +513K +5.11% Jun 30, 2018 10-Q 2018-08-14
Q1 2018 10.6M +528K +5.26% Mar 31, 2018 10-Q 2018-05-03
Q4 2017 10.3M +7.01M +215% Dec 31, 2017 10-K 2019-03-12
Q3 2017 10.3M Sep 30, 2017 10-Q 2017-11-09
Q2 2017 10M Jun 30, 2017 10-Q 2017-08-11
Q1 2017 10M Mar 31, 2017 10-Q 2017-05-12
Q4 2016 3.26M Dec 31, 2016 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.